The FDA approved gepotidacin (Blujepa), an oral option for the treatment of uncomplicated urogenital gonorrhea among patients ages 12 years and older, GSK announced on Thursday. "The ability of N.
Hosted on MSN
How gonorrhea impacts the body
Explore the effects of gonorrhea on the body and why early detection and treatment are crucial. Alzheimer's Scientists Reveal New Early Warning Sign With the penny going away, what should you do with ...
In February 1990, world heavyweight champion Mike Tyson, boasting a record of 37 wins and no defeats, faced up against James ‘Buster’ Douglas in Tokyo, in what every boxing expert agreed would be ...
Why do college football QBs clap? Illustration: Kelsea Petersen / The Athletic; Icon Sportswire / Getty Remember when it was your turn to be quarterback? In the cozy confines of a backyard or in the ...
Well, it looks like my plan to slowly deduce who the Secret Traitor is by keeping a running tally of the contestants who made it on to their nightly murder shortlist was all for nothing. Just three ...
Merck & Co. Inc. (NYSE: MRK) will not exercise its option for Evaxion A/S (NASDAQ: EVAX) Gonorrhea vaccine candidate EVX-B2. Gonorrhoea is a common, sexually transmitted infection caused by Neisseria ...
The FDA on Friday announced approval of zoliflodacin (Nuzolvence) as an oral treatment for gonorrhea, a day after approving oral gepotidacin (Blujepa) for the same indication. Zoliflodacin is the ...
Mohsen Baqery is a Staff Writer at GameRant based in Turkey. He mainly covers video game news and industry features while occasionally publishing guides and listicles. Mohsen started his journey into ...
(RTTNews) - Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (INVA), announced that the U.S. Food and Drug Administration approved NUZOLVENCE (zoliflodacin) for oral suspension, a first ...
After a three-decade drought of new antibiotics to treat gonorrhea, the FDA has signed off on two first-in-class oral treatments for the sexually transmitted infection (STI), which affects more than ...
FDA approval was based on results from the largest Phase 3 clinical trial ever conducted for a new treatment against Neisseria gonorrhoeae infection in regions with a high prevalence of gonorrhea ...
With an increase in the antimicrobial resistance to therapies for gonorrhea, doctors have been left with fewer options to treat the sexually transmitted infection (STI), which strikes more an 80 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results